This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Prabir K. Chaudhuri, MD; Bina Chaudhuri, MD; Nili Patel

Arch Surg. 1986;121(11):1322-1325.

Abstract
• It has been proposed that a nonsteroidal hormone such as insulin may directly exert an influence through estrogen receptors and alter the biologic behavior of steroid hormone target tissue. The implication of such a proposal is that diabetes may alter the outcome of estrogen receptor—positive tumors such as breast or endometrial carcinomas. To evaluate the effect of insulin on a receptor-positive tumor, we examined the direct effect of insulin on an estrogen receptor and its subsequent biologic effect on a receptor-positive endometrial carcinoma model in vitro and in vivo. An in vitro experiment demonstrated that when the estrogen receptor—positive cell line was grown in serum-free media with low insulin, there was a loss of intracellular receptors for estrogen. This loss of estrogen receptors was also associated with increased growth rate as reflected by increased thymidine uptake. Similarly, in vivo experiments demonstrated that a diabetic host with a high blood glucose level and a low insulin level exhibited development of growth of a receptor-negative tumor with accelerated growth rate in contrast to growth of a receptor-positive tumor with slower growth rate in a normal host with normal serum insulin and blood glucose levels. Data suggest that insulin may modulate the growth of estrogen receptor—positive tumors through its direct effect on estrogen receptors.

(Arch Surg 1986;121:1322-1325)

Author Affiliations
From the Department of Surgery, Loyola University of Chicago, Maywood (Dr P. Chaudhuri and Ms Patel), and the Department of Pathology, Hinsdale (Ill) Hospital (Dr B. Chaudhuri). Dr P. Chaudhuri is now with the Medical College of Ohio, Toledo.

Footnotes
Accepted for publication July 31, 1986.

Read before the 39th Annual Meeting of the Society of Surgical Oncology, Washington, DC, May 13, 1986.

Reprint requests to Division of Surgical Oncology, Department of Surgery, Medical College of Ohio, Toledo, OH 43699 (Dr P. Chaudhuri).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue and Michels
Am. J. Clin. Nutr. 2007;86:823S-835S.
ABSTRACT | FULL TEXT  

Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer
Nardon et al.
J. Clin. Pathol. 2003;56:599-604.
ABSTRACT | FULL TEXT  

Fasting Glucose Is a Risk Factor For Breast Cancer: A Prospective Study
Muti et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:1361-1368.
ABSTRACT | FULL TEXT